Innospec (IOSP) EBITDA Margin (2010 - 2026)

Innospec has disclosed EBITDA Margin across 17 years of filings, most recently posting 8.05% for Q1 2026.

• EBITDA Margin for Q1 2026 came in at 8.05%, down 159.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 1.28% (down 823.0% YoY), and the FY2025 annual result was 1.63%, down 801.0% from the prior year.
• EBITDA Margin came in at 8.05% for Q1 2026 at Innospec, up from 11.79% in the prior quarter.
• In the past five years, EBITDA Margin ranged from a high of 10.28% in Q3 2024 to a low of 11.79% in Q4 2025.
• The 5-year median for EBITDA Margin is 9.03% (2023), against an average of 7.35%.
• Across the five-year window, EBITDA Margin surged 224 bps in 2024 and tumbled 2059 bps in 2025, its largest moves.
• Innospec's EBITDA Margin stood at 9.12% in 2022, then fell by 1 bps to 9.0% in 2023, then dropped by 2 bps to 8.8% in 2024, then slumped by 234 bps to 11.79% in 2025, then jumped by 168 bps to 8.05% in 2026.
• The last three EBITDA Margin figures came in at 8.05% (Q1 2026), 11.79% (Q4 2025), and 1.34% (Q3 2025), per Business Quant data.